AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 281: G1468-G1476, 2001;
0193-1857/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Viramontes, B. E.
Right arrow Articles by Zinsmeister, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Viramontes, B. E.
Right arrow Articles by Zinsmeister, A. R.
Vol. 281, Issue 6, G1468-G1476, December 2001

Effects of an alpha 2-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans

Blanca E. Viramontes1, Allison Malcolm1, Michael Camilleri1, Lawrence A. Szarka1, Sanna McKinzie1, Duane D. Burton1, and Alan R. Zinsmeister2

1 Enteric Neuroscience Program, Gastroenterology Research Unit and 2 Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905

To characterize alpha 2-adrenergic control of motor and sensory functions of gastrointestinal tract and colon, we studied dose-related effects of clonidine (placebo or up to 0.3 mg po) by random assignment in 55 healthy humans. Gastrointestinal transit was measured in all subjects; in 35, we assessed colonic compliance, tone, and sensations of gas and pain during phasic distensions. Clonidine did not significantly alter gastrointestinal or colonic transit, but it increased colonic compliance and reduced fasting tone without altering colonic response to a meal. Clonidine significantly reduced aggregate sensation to distensions overall and had significant linear dose-related sensory effects at 8- and 24-mmHg distensions. Effect on pain (including dose-response relationship) was due to 0.3-mg dose for distensions at 24 mmHg. We confirmed that clonidine relaxes fasting colonic tone and reduces sensation of pain. In this study, gut transit was not altered by clonidine, and novel dose-response characteristics and clonidine's effect on gas sensation are provided. Doses as low as 0.05 mg may be effective and potentially useful in reducing colonic tone and gas sensation.

clonidine; compliance; transit; alpha 2-adrenoreceptor


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. Camilleri, I. Busciglio, P. Carlson, S. McKinzie, D. Burton, K. Baxter, M. Ryks, and A. R. Zinsmeister
Candidate genes and sensory functions in health and irritable bowel syndrome
Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G219 - G225.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
M. Camilleri
{alpha}2{delta} ligand: a new, smart pill for visceral pain in patients with hypersensitive irritable bowel syndrome?
Gut, October 1, 2007; 56(10): 1337 - 1338.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Delgado-Aros, H. J. Chial, M. Camilleri, L. A. Szarka, F. T. Weber, J. Jacob, I. Ferber, S. McKinzie, D. D. Burton, and A. R. Zinsmeister
Effects of a kappa -opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans
Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G558 - G566.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online